Market Overview:
The global traumatic brain injuries (TBI) treatment market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to the increasing incidence of TBI, rising awareness about TBI and its treatment, and technological advancements in the field of TBI treatment. The global traumatic brain injuries (TBI) treatment market is segmented on the basis of type, application, and region. On the basis of type, the market is segmented into surgery and drugs. Surgery is further sub-segmented into craniotomy surgery, craniectomy surgery, decompressive craniectomy surgery,, evacuation surgery,, hemicraniectomy,, lobar resection,, stereotactic radiosurgery,. Drugs are further sub-segmented into corticosteroids drugs., anticonvulsants drugs., glutamate receptor antagonists drugs., erythropoietin stimulating agents (ESA). On the basis of application,. Hospitals are further sub-segmented into general hospitals., neurosurgical hospitals. Neurologist Centers are further sub-segmented into standalone neurologist centers., neurology clinics within general hospitals. Pharmacy are further sub-segmented into retail pharmacy chains., hospital pharmacies. Geographically,.
Product Definition:
Traumatic brain injury (TBI) is a type of head injury that results from an external force that damages the brain. TBI can range from a mild concussion to a life-threatening injury. Symptoms of TBI may include headache, dizziness, nausea, vomiting, confusion, disorientation, impaired judgment, slowed thinking process,, memory problems and mood changes.
Traumatic Brain Injuries Treatment is important because it can help individuals with TBI recover their physical and cognitive abilities. Treatment may include medication for headaches or other symptoms; physical therapy to improve movement and function; speech therapy to improve communication skills; occupational therapy to help with daily activities such as dressing or bathing; and counseling for mood changes or other psychological issues.
Surgery:
It is a medical procedure that is used to correct or repair a health problem by removing, repairing, or restoring body parts. The main goal of surgery is to cure or improve the condition and prevent further injury or illness. Surgery can be performed on any part of the body and has been used as an effective treatment for many diseases over the past. It has also helped in saving many lives by helping people who are critically ill but cannot be treated with medication alone.
Drugs:
The global drugs and its usage in traumatic brain injuries treatment market is expected to witness significant growth over the forecast period. The major factor that propels the growth of this market includes increasing incidences of Traumatic Brain Injuries (TBI) due to fall, gunshot, road traffic accidents, etc. Moreover, growing geriatric population base coupled with rising awareness levels about brain injury treatment also contributes towards the expansion of Drugs and its usage in TBI Treatment market globally.
North America Drugs.
Application Insights:
Based on application, the global traumatic brain injuries treatment market is segmented into hospitals, neurologist centers and pharmacy. The hospital segment dominated the overall market in terms of revenue in 2017. This can be attributed to factors such as a high prevalence of traumatic brain injuries coupled with rising awareness about early diagnosis and effective management procedures for these conditions. According to data published by WHO, globally around 250,000 people die due to TBIs every year along with another 2 million who suffer from severe TBIs that require medical attention.
The increasing number of patients suffering from head trauma resulting in TBIs has led healthcare providers across the globe to develop innovative treatment options for early diagnosis and effective management procedures for these conditions which is driving demand for treatments at hospitals level. On the other hand, neurologist centers are anticipated to witness lucrative growth over forecast period owing to an increase in cases diagnosed with mild-to-moderate Traumatic Brain Injury (TBI) or mild cognitive impairment (MCI).
Regional Analysis:
North America dominated the global traumatic brain injuries treatment market in 2017. This can be attributed to factors such as favorable healthcare infrastructure, high awareness levels coupled with high disposable income of patients and their families. In addition, a rise in road accidents is also one of the major causes for this regional growth. According to WHO data, approximately 1.3 million people die due to road traffic injuries every year in North America alone and this number is increasing rapidly due to lack of safety measures on roadsides coupled with drink & drive incidents and other vehicular crimes committed by drivers under influence of alcohol or drugs (illegal or not).
In Asia Pacific region as well, Japan leads this market owing its advanced medical technologies along with a large population suffering from TBIs after disasters such as earthquakes or hurricanes that occur quite often in countries like Chile.
Growth Factors:
- Increasing incidence of traumatic brain injuries (TBI) due to road accidents, violence, and sports injuries.
- Growing awareness about the symptoms and long-term effects of TBIs among people.
- Rising demand for better diagnosis and treatment options for TBIs.
- Availability of government funding for research on TBIs treatment therapies.
Scope Of The Report
Report Attributes
Report Details
Report Title
Traumatic Brain Injuries Treatment Market Research Report
By Type
Surgery, Drugs
By Application
Hospitals, Neurologist Centers, Pharmacy
By Companies
Neuren Pharmaceuticals, TEVA Pharmaceutical Industries, Grace Laboratories, NeuroScience Pharmaceuticals, Tenax Therapeutics, Ischemix, Vasopharm, Amarantus BioScience, Silver Creek Pharmaceuticals, Stemedica Cell Technologies, Banayan Biomarkers
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
214
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Traumatic Brain Injuries Treatment Market Report Segments:
The global Traumatic Brain Injuries Treatment market is segmented on the basis of:
Types
Surgery, Drugs
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Neurologist Centers, Pharmacy
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Neuren Pharmaceuticals
- TEVA Pharmaceutical Industries
- Grace Laboratories
- NeuroScience Pharmaceuticals
- Tenax Therapeutics
- Ischemix
- Vasopharm
- Amarantus BioScience
- Silver Creek Pharmaceuticals
- Stemedica Cell Technologies
- Banayan Biomarkers
Highlights of The Traumatic Brain Injuries Treatment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgery
- Drugs
- By Application:
- Hospitals
- Neurologist Centers
- Pharmacy
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Traumatic Brain Injuries Treatment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Treatment for traumatic brain injuries typically includes physical therapy, speech therapy, and rehabilitation.
Some of the major companies in the traumatic brain injuries treatment market are Neuren Pharmaceuticals, TEVA Pharmaceutical Industries, Grace Laboratories, NeuroScience Pharmaceuticals, Tenax Therapeutics, Ischemix, Vasopharm, Amarantus BioScience, Silver Creek Pharmaceuticals, Stemedica Cell Technologies, Banayan Biomarkers.
The traumatic brain injuries treatment market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Traumatic Brain Injuries Treatment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Traumatic Brain Injuries Treatment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Traumatic Brain Injuries Treatment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Traumatic Brain Injuries Treatment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Traumatic Brain Injuries Treatment Market Size & Forecast, 2020-2028
4.5.1 Traumatic Brain Injuries Treatment Market Size and Y-o-Y Growth
4.5.2 Traumatic Brain Injuries Treatment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Surgery
5.2.2 Drugs
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Neurologist Centers
6.2.3 Pharmacy
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Traumatic Brain Injuries Treatment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Traumatic Brain Injuries Treatment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Surgery
9.6.2 Drugs
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Neurologist Centers
9.10.3 Pharmacy
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Surgery
10.6.2 Drugs
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Neurologist Centers
10.10.3 Pharmacy
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Surgery
11.6.2 Drugs
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Neurologist Centers
11.10.3 Pharmacy
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Surgery
12.6.2 Drugs
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Neurologist Centers
12.10.3 Pharmacy
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Surgery
13.6.2 Drugs
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Neurologist Centers
13.10.3 Pharmacy
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Traumatic Brain Injuries Treatment Market: Competitive Dashboard
14.2 Global Traumatic Brain Injuries Treatment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Neuren Pharmaceuticals
14.3.2 TEVA Pharmaceutical Industries
14.3.3 Grace Laboratories
14.3.4 NeuroScience Pharmaceuticals
14.3.5 Tenax Therapeutics
14.3.6 Ischemix
14.3.7 Vasopharm
14.3.8 Amarantus BioScience
14.3.9 Silver Creek Pharmaceuticals
14.3.10 Stemedica Cell Technologies
14.3.11 Banayan Biomarkers
